Alpha Paradigm Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Alpha Paradigm Partners’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$233K	Buy	+1,132	New	+$286K	0.1%	291

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Paradigm Partners's SWAV Position: Q4 2022 in Review

Alpha Paradigm Partners opened a new position in Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022: 1,132 shares worth $233K. The stake represents 0.1% of the portfolio and ranks #291 among its holdings.

415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

Alpha Paradigm Partners held 1,132 shares of Shockwave Medical, Inc. Common Stock worth $233K as of Q4 2022.
Shockwave Medical, Inc. Common Stock was a new Alpha Paradigm Partners position in Q4 2022.
Shockwave Medical, Inc. Common Stock made up 0.1% of Alpha Paradigm Partners's portfolio in Q4 2022, its #291 holding.
415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.